[Federal Register Volume 67, Number 163 (Thursday, August 22, 2002)]
[Notices]
[Page 54441]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-21347]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Statement of Organization, Functions, and Delegations of 
Authority

    Part N, National Institutes of Health, of the Statement of 
Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (40 FR 22859, May 27, 1975, as 
amended most recently at 66 FR 21406, April 30, 2001, and redesignated 
from Part HN as Part N at 60 FR 56606, November 9, 1995) is amended as 
set forth below to reflect the transfer of the bacterial toxins and 
therapeutics research function from the National Institute of Dental 
and Craniofacial Research to the National Institute of Allergy and 
Infectious Diseases, National Institutes of Health.
    Section N-B, Organization and Functions, under the heading National 
Institute of Allergy and Infectious Diseases (NM, formerly HNM), 
Division of Intramural Research (NM2, formerly HNM2), insert the 
following:
    Bacterial Toxins and Therapeutics Section (NM-8, formerly HNM2-8). 
(1) Studies the actions of bacterial protein toxins on animal cells, 
using methods of biochemistry, microbiology, genetics, and cell 
biology; and (2) focuses on pathogenic bacteria, especially Bacillus 
antracis, to include (a) identification and analysis of bacterial 
virulence factors and their genetic regulation, (b) structure-function 
analysis of bacterial toxin proteins and other virulence factors, and 
(c) development of improved vaccines and therapeutics.
    Delegations of Authority Statement: All delegations and 
redelegations of authority to officers and employees of NIH that were 
in effect immediately prior to the effective date of this establishment 
and are consistent with this establishment shall continue in effect, 
pending further redelegation.

    Dated: August 11, 2002.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 02-21347 Filed 8-21-02; 8:45 am]
BILLING CODE 4140-01-M